Skip to content

Reducing ADHD Overdiagnosis by 30%: Creyos and Telapsychiatry

As patient requests for ADHD testing rise, so do provider concerns about overdiagnosis and overmedication. Using the objective cognitive data he gathers using Creyos, Dr. Toy curbs ADHD overdiagnosis by more than 30%—accurately identifying ADHD, meeting accommodation needs, and improving symptoms within 2–3 months.

That’s why they use Creyos.

Client Name:

Telapsychiatry

Number of Patients:

700 monthly

Location:

Across 10 states

30% reduced overdiagnosis

meaning Telapsychiatry more accurately diagnoses ADHD

2–3 months

symptom improvement for ADHD patients

Introducing Dr. Toy and Telapsychiatry

Making ADHD Testing Accessible

Telapsychiatry is a growing private practice of 12 providers, currently serving patients across 10 states. Dr. Toy himself sees about 150 patients a month, of the practices’ total 700 monthly volume, in addition to handling administration. 

The practice has a particular focus on accessibility and health equity: expanding its pay structure to include insurances, and delivering care through telemedicine to reach a wider range of patients. Increasingly, Dr. Toy has seen his adult patients (18–60 years old) come in with concerns about memory, focus, attention, and potential ADHD.

During the pandemic, so many adults came to us with trouble focusing, with no history of ADHD. It was difficult to make an assessment using only subjective evaluation. And getting academic records from a person’s childhood is almost impossible. We needed a different solution.
Dr. Toy Medical Director Telapsychiatry

The Challenges

  • Nearly 80% of patients seek ADHD assessment, coming to the private practice with concerns about memory, focus, attention, concentration. These high rates of demand lead to concerns about overdiagnosis and overmedication—if adequate testing is not available.
  • Subjective methods alone are incomplete. It’s difficult to determine the exact cause of inattention symptoms using only the standard Adult ADHD Self-Report Scale (ASRS).

The Solutions

  • Administering the ADHD Condition-Focused Protocol through Creyos enables Dr. Toy to quickly gather objective data and more clearly determine the source of symptoms.

The Results

  • Dr. Toy uses objective data to curb ADHD diagnosis by over 30%. Of the 80% of patients who come in with ADHD concerns, he accurately diagnoses 30%–50% who truly have ADHD, as well as accurately ruling out ADHD in other patients with inattention.
  • Dr. Toy can more quickly and confidently determine a treatment and medication plan for ADHD patients, resulting in symptom improvement within 2–3 months.
  • Accommodation needs are met quickly for ADHD patients, particularly adults who face obstacles to getting the diagnosis they need to seek treatment and support. Dr. Toy’s office can quickly and efficiently deliver the documentation they need for work or school.

Your Guide In Objective Measurement
of Patient Cognition

Read the full case study to learn how Gabrielle Thompson and GT Healthcare use Creyos Health to deliver confident, data-driven mental health care and improve patient outcomes.

Download The Case Study
Creyos and GT Healthcare - Title Card

Start Using the Creyos ADHD Condition-Focused Protocol

Backed by over 30 years of research, Creyos helps you confidently measure markers of ADHD and changes in cognitive performance —and deliver better patient outcomes, faster.

Request a Demo

Join thousands of healthcare professionals who receive a monthly update on the latest research and news in brain health.